Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 45 Neoplasms 6 Colorectal Neoplasms 5 Neoplasm Metastasis 4 Adenocarcinoma 3 Resectable Pancreatic Cancer 2 Rectal Neoplasms 2 Pancreatic Cancer Metastatic 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Urachal cancer 1 Stomach Neoplasms 1 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Pancreatic Cancer Non-resectable 1 Pancreatic Adenocarcinoma 1 Neoplasms, Basal Cell 1 Locally Advanced Unresectable or Metastatic Solid Tumors 1 Locally Advanced Pancreatic Adenocarcinoma 1 Localized Pancreatic Adenocarcinoma 1 Gastrointestinal Neoplasms 1 Gastroesophageal Adenocarcinoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Islet Cell 1 Carcinoma 1 Borderline Resectable Pancreatic Cancer 1

Interventions

Oxaliplatin 295 Capecitabine 209 Fluorouracil 183 Cisplatin 172 Docetaxel 140 S 1 (combination) 135 Paclitaxel 128 Leucovorin 117 Irinotecan 110 pembrolizumab 104 Trastuzumab 75 Nivolumab 59 apatinib 57 Drug Therapy 52 sintilimab 46 Surgical Procedures, Operative 45 Ramucirumab 40 Radiotherapy 40 Bevacizumab 37 Hyperthermic Intraperitoneal Chemotherapy 34 Epirubicin 32 titanium silicide 31 tislelizumab 31 Carboplatin 31 Gastrectomy 28 Cyclophosphamide 27 XELOX 25 Tegafur 24 Folfox protocol 23 Albumin-Bound Paclitaxel 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × folfirinox × Clear all

NCT03825861 2020-11-10

FOLFIRINOX

Instituto do Cancer do Estado de São Paulo

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡